Neurotransmitters In Anxiety Essay

Neurotransmitters in AnxietyHolly WeeksUMGCPSYC 301 E030 Professor ThompsonFebruary 27th, 2022Neurotransmitters in AnxietyArguably, anxiety disorders are prevalent in the general population and lower the quality of life. Anxiety disorder is the most common mental health disorder within the general population and encompasses a group of disorders with extreme disturbance of moods and “emotional tones” (Adwas et al., 2019, p. 580). Anxiety co-occurs with other psychiatric conditions and has high economic and social costs on the affected individuals. In the United States, 31.1% of the general population experience one form of anxiety disorder at some point in their lives (National Institute of Mental Health [NIMH] 2022). The degree of impairment also varies from mild to severe, but a large percentage of the general population experience mild impairments. The etiology of anxiety disorder differs with some form of anxiety, such as panic disorder having a genetic cause. Concerning pathophysiology, the mechanism of anxiety is unknown. However, a wide range of neurotransmitters is responsible for influencing the pathogenesis of anxiety. Based on this premise, adopting the